---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-039726"
form_type: "8-K"
ticker: "TIL"
cik: "0001789769"
company_name: "Instil Bio, Inc."
filed_at: "2024-09-06T23:59:59+00:00"
generated_at: "2026-05-31T06:06:04.284906+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Instil Bio to close remaining UK operations, cut workforce, incur up to $5.5M in restructuring costs

## Summary
- Board approved restructuring plan to close Manchester, UK operations and eliminate remaining UK workforce.
- Estimated aggregate restructuring costs up to $5.5M, including asset impairment ($2.2M), severance ($2.0M), and contract termination ($1.3M).
- Workforce reduction expected to be substantially complete by end of 2024.
- Charges are subject to assumptions; additional costs may arise not currently contemplated.

## SEC filing metadata
- accession: 0001628280-24-039726
- form_type: 8-K
- ticker: TIL
- cik: 0001789769
- company_name: Instil Bio, Inc.
- filed_at: 2024-09-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789769/000162828024039726/0001628280-24-039726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789769/000162828024039726/til-20240901.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-039726
- JSON: https://secwatch.observer/filing/0001628280-24-039726.json
- Plain text: https://secwatch.observer/filing/0001628280-24-039726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.